| Literature DB >> 34758970 |
Maike Winters1, Ben Oppenheim2,3, Paul Sengeh4, Mohammad B Jalloh4, Nance Webber4, Samuel Abu Pratt4, Bailah Leigh5, Helle Molsted-Alvesson6, Zangin Zeebari7, Carl Johan Sundberg8, Mohamed F Jalloh6, Helena Nordenstedt6.
Abstract
INTRODUCTION: Infectious disease misinformation is widespread and poses challenges to disease control. There is limited evidence on how to effectively counter health misinformation in a community setting, particularly in low-income regions, and unsettled scientific debate about whether misinformation should be directly discussed and debunked, or implicitly countered by providing scientifically correct information.Entities:
Keywords: epidemiology; malaria; public health; randomised controlled trial; typhoid and paratyphoid fevers
Mesh:
Year: 2021 PMID: 34758970 PMCID: PMC8578963 DOI: 10.1136/bmjgh-2021-006954
Source DB: PubMed Journal: BMJ Glob Health ISSN: 2059-7908
Core messages of audio dramas by intervention group
| Episode | Group A: Plausible Alternative | Group B: Avoiding Misinformation |
| 1. Disease | People think there is a disease called typhoid-malaria, but these are two different diseases. | You can get typhoid by itself, without having other diseases. |
| 2. Cause | Typhoid is not caused by mosquitoes, but by contaminated water and food. | Typhoid is caused by contaminated water and food. |
| 3. Prevention | Sleeping under a bednet helps prevent malaria but does not help prevent typhoid. Good hygiene, drinking treated water and cooking food properly help prevent typhoid. | Prevent yourself from getting typhoid by cooking your food properly and drinking only treated water. |
| 4. Repetition | Repetition of core messages of episodes 1–3. | Repetition of core messages in episodes 1–3. |
Figure 1Flow chart of the Contagious Misinformation Trial.
Baseline characteristics of the intervention and control groups
| Group A | Group B | Control | P value* | |
| Age (years) | ||||
| 169 (69%) | 163 (67%) | 151 (62%) | 0.147 | |
| 59 (24%) | 74 (29%) | 73 (30%) | ||
| 18 (7%) | 10 (4%) | 21 (9%) | ||
| Sex | ||||
| 118 (48%) | 127 (52%) | 130 (53%) | 0.499 | |
| 128 (52%) | 118 (48%) | 115 (47%) | ||
| Education | ||||
| 17 (7%) | 9 (4%) | 18 (7%) | 0.226 | |
| 14 (6%) | 12 (5%) | 12 (5%) | ||
| 133 (54%) | 126 (51%) | 142 (58%) | ||
| 82 (33%) | 98 (40%) | 72 (29%) | ||
| Religion | ||||
| 155 (63%) | 141 (58%) | 149 (61%) | 0.461 | |
| 91 (37%) | 104 (42%) | 96 (39%) | ||
| Income (leones)† | ||||
| 175 (71%) | 158 (64%) | 160 (65%) | 0.418 | |
| 60 (24%) | 68 (28%) | 69 (28%) | ||
| 11 (4%) | 19 (8%) | 16 (7%) | ||
| Typhoid from mosquitoes? | ||||
| 94 (38%) | 100 (41%) | 93 (38%) | 0.648 | |
| 123 (50%) | 122 (50%) | 128 (52%) | ||
| 26 (11%) | 23 (9%) | 23 (9%) | ||
| 3 (1%) | 0 (0%) | 1 (0%) | ||
| Typhoid without malaria? | ||||
| 145 (59%) | 146 (60%) | 142 (58%) | 0.827 | |
| 83 (34%) | 86 (35%) | 89 (36%) | ||
| 17 (7%) | 13 (5%) | 14 (6%) | ||
| 1 (0%) | 0 (0%) | 0 (0%) |
Data are n (%).
*Based on χ2 test.
†At the time of the baseline survey 10.000 leones was worth approximately US$1.
Primary outcomes for intervention group A and group B versus control group
| Crude OR | P value | Adjusted* OR | P value | |
|
| ||||
| Intention-to-treat | ||||
| Group A | 0.31 (0.20 to 0.48) | 0.000 | 0.29 (0.18 to 0.47) | 0.000 |
| Group B | 0.50 (0.33 to 0.77) | 0.002 | 0.61 (0.39 to 0.95) | 0.029 |
| Control | Reference | – | Reference | – |
| Per-protocol | ||||
| Group A | 0.07 (0.02 to 0.19) | 0.000 | 0.06 (0.02 to 0.20) | 0.000 |
| Group B | 0.31 (0.14 to 0.70) | 0.005 | 0.35 (0.15 to 0.84) | 0.019 |
| Control | Reference | – | Reference | – |
| As-treated | ||||
| Group A | 0.15 (0.08 to 0.27) | 0.000 | 0.13 (0.07 to 0.25) | 0.000 |
| Group B | 0.33 (0.19 to 0.57) | 0.000 | 0.38 (0.21 to 0.68) | 0.001 |
| Control | Reference | – | Reference | – |
|
| ||||
| Intention-to-treat | ||||
| Group A | 0.32 (0.21 to 0.48) | 0.000 | 0.29 (0.19 to 0.45) | 0.000 |
| Group B | 0.49 (0.33 to 0.73) | 0.000 | 0.55 (0.36 to 0.83) | 0.004 |
| Control | Reference | – | Reference | – |
| Per-protocol | ||||
| Group A | 0.07 (0.03 to 0.18) | 0.000 | 0.06 (0.02 to 0.15) | 0.000 |
| Group B | 0.16 (0.07 to 0.36) | 0.000 | 0.15 (0.06 to 0.36) | 0.000 |
| Control | Reference | – | Reference | – |
| As-treated | ||||
| Group A | 0.13 (0.08 to 0.23) | 0.000 | 0.12 (0.07 to 0.21) | 0.000 |
| Group B | 0.25 (0.15 to 0.42) | 0.000 | 0.27 (0.16 to 0.47) | 0.000 |
| Control | Reference | – | Reference | – |
*Adjusted for sex, education, religion, income and age.
†Complete case analysis. Participants who responded ‘Don’t Know’ or ‘No Response’ in either baseline or endline were excluded. We analysed the impact of intervention assignment on endline non-response (see online supplemental table S9).
Primary outcomes for intervention group A versus group B
| Crude OR | P value | Adjusted* OR | P value | |
|
| ||||
| Intention-to-treat | ||||
| Group A | 0.61 (0.39 to 0.96) | 0.039 | 0.46 (0.28 to 0.76) | 0.002 |
| Group B | Reference | – | Reference | – |
| Per-protocol | ||||
| Group A | 0.23 (0.08 to 0.73) | 0.012 | 0.15 (0.04 to 0.58) | 0.006 |
| Group B | Reference | – | Reference | – |
| As-treated | ||||
| Group A | 0.47 (0.27 to 0.82) | 0.008 | 0.33 (0.19 to 0.64) | 0.001 |
| Group B | Reference | – | Reference | – |
|
| ||||
| Intention-to-treat | ||||
| Group A | 0.65 (0.43 to 0.98) | 0.040 | 0.51 (0.33 to 0.81) | 0.004 |
| Group B | Reference | – | Reference | – |
| Per-protocol | ||||
| Group A | 0.43 (0.15 to 1.25) | 0.121 | 0.32 (0.09 to 1.09) | 0.069 |
| Group B | Reference | – | Reference | – |
| As-treated | ||||
| Group A | 0.55 (0.32 to 0.96) | 0.033 | 0.47 (0.26 to 0.84) | 0.011 |
| Group B | Reference | – | Reference | – |
*Adjusted for sex, education, religion, income and age.
†Complete case analysis. Participants who responded ‘Don’t Know’ or ‘No Response’ in either baseline or endline were excluded.